BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 30850682)

  • 1. A Novel Lactate Dehydrogenase Inhibitor, 1-(Phenylseleno)-4-(Trifluoromethyl) Benzene, Suppresses Tumor Growth through Apoptotic Cell Death.
    Kim EY; Chung TW; Han CW; Park SY; Park KH; Jang SB; Ha KT
    Sci Rep; 2019 Mar; 9(1):3969. PubMed ID: 30850682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double genetic disruption of lactate dehydrogenases A and B is required to ablate the "Warburg effect" restricting tumor growth to oxidative metabolism.
    Ždralević M; Brand A; Di Ianni L; Dettmer K; Reinders J; Singer K; Peter K; Schnell A; Bruss C; Decking SM; Koehl G; Felipe-Abrio B; Durivault J; Bayer P; Evangelista M; O'Brien T; Oefner PJ; Renner K; Pouysségur J; Kreutz M
    J Biol Chem; 2018 Oct; 293(41):15947-15961. PubMed ID: 30158244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a potent inhibitor targeting human lactate dehydrogenase A and its metabolic modulation for cancer cell line.
    Chen CY; Feng Y; Chen JY; Deng H
    Bioorg Med Chem Lett; 2016 Jan; 26(1):72-5. PubMed ID: 26597536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lactate dehydrogenase downregulation mediates the inhibitory effect of diallyl trisulfide on proliferation, metastasis, and invasion in triple-negative breast cancer.
    Cheng SY; Yang YC; Ting KL; Wen SY; Viswanadha VP; Huang CY; Kuo WW
    Environ Toxicol; 2017 Apr; 32(4):1390-1398. PubMed ID: 27566995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myristica fragrans Suppresses Tumor Growth and Metabolism by Inhibiting Lactate Dehydrogenase A.
    Kim EY; Choi HJ; Park MJ; Jung YS; Lee SO; Kim KJ; Choi JH; Chung TW; Ha KT
    Am J Chin Med; 2016; 44(5):1063-79. PubMed ID: 27430914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural and functional regulation of lactate dehydrogenase-A in cancer.
    Woodford MR; Chen VZ; Backe SJ; Bratslavsky G; Mollapour M
    Future Med Chem; 2020 Mar; 12(5):439-455. PubMed ID: 32064930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of novel human lactate dehydrogenase A inhibitors: High-throughput screening, synthesis, and biological evaluations.
    Zhou Y; Tao P; Wang M; Xu P; Lu W; Lei P; You Q
    Eur J Med Chem; 2019 Sep; 177():105-115. PubMed ID: 31129449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and initial screening of lactate dehydrogenase inhibitor activity of 1,3-benzodioxole derivatives.
    Annas D; Cheon SY; Yusuf M; Bae SJ; Ha KT; Park KH
    Sci Rep; 2020 Nov; 10(1):19889. PubMed ID: 33199724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphorylation-mediated activation of LDHA promotes cancer cell invasion and tumour metastasis.
    Jin L; Chun J; Pan C; Alesi GN; Li D; Magliocca KR; Kang Y; Chen ZG; Shin DM; Khuri FR; Fan J; Kang S
    Oncogene; 2017 Jul; 36(27):3797-3806. PubMed ID: 28218905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic plasticity underpins innate and acquired resistance to LDHA inhibition.
    Boudreau A; Purkey HE; Hitz A; Robarge K; Peterson D; Labadie S; Kwong M; Hong R; Gao M; Del Nagro C; Pusapati R; Ma S; Salphati L; Pang J; Zhou A; Lai T; Li Y; Chen Z; Wei B; Yen I; Sideris S; McCleland M; Firestein R; Corson L; Vanderbilt A; Williams S; Daemen A; Belvin M; Eigenbrot C; Jackson PK; Malek S; Hatzivassiliou G; Sampath D; Evangelista M; O'Brien T
    Nat Chem Biol; 2016 Oct; 12(10):779-86. PubMed ID: 27479743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting the monocarboxylate transporter MCT2 and lactate dehydrogenase A LDHA in cancer cells with FX-11 and AR-C155858 inhibitors.
    Alobaidi B; Hashimi SM; Alqosaibi AI; AlQurashi N; Alhazmi S
    Eur Rev Med Pharmacol Sci; 2023 Jul; 27(14):6605-6617. PubMed ID: 37522672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PGC1β regulates multiple myeloma tumor growth through LDHA-mediated glycolytic metabolism.
    Zhang H; Li L; Chen Q; Li M; Feng J; Sun Y; Zhao R; Zhu Y; Lv Y; Zhu Z; Huang X; Xie W; Xiang W; Yao P
    Mol Oncol; 2018 Sep; 12(9):1579-1595. PubMed ID: 30051603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression.
    Le A; Cooper CR; Gouw AM; Dinavahi R; Maitra A; Deck LM; Royer RE; Vander Jagt DL; Semenza GL; Dang CV
    Proc Natl Acad Sci U S A; 2010 Feb; 107(5):2037-42. PubMed ID: 20133848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lactate dehydrogenase A negatively regulated by miRNAs promotes aerobic glycolysis and is increased in colorectal cancer.
    Wang J; Wang H; Liu A; Fang C; Hao J; Wang Z
    Oncotarget; 2015 Aug; 6(23):19456-68. PubMed ID: 26062441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stable shRNA Silencing of Lactate Dehydrogenase A (LDHA) in Human MDA-MB-231 Breast Cancer Cells Fails to Alter Lactic Acid Production, Glycolytic Activity, ATP or Survival.
    Mack N; Mazzio EA; Bauer D; Flores-Rozas H; Soliman KF
    Anticancer Res; 2017 Mar; 37(3):1205-1212. PubMed ID: 28314283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Galloflavin, a new lactate dehydrogenase inhibitor, induces the death of human breast cancer cells with different glycolytic attitude by affecting distinct signaling pathways.
    Farabegoli F; Vettraino M; Manerba M; Fiume L; Roberti M; Di Stefano G
    Eur J Pharm Sci; 2012 Nov; 47(4):729-38. PubMed ID: 22954722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. JQ1 suppresses tumor growth through downregulating LDHA in ovarian cancer.
    Qiu H; Jackson AL; Kilgore JE; Zhong Y; Chan LL; Gehrig PA; Zhou C; Bae-Jump VL
    Oncotarget; 2015 Mar; 6(9):6915-30. PubMed ID: 25762632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological or genetic inhibition of LDHA reverses tumor progression of pediatric osteosarcoma.
    Gao S; Tu DN; Li H; Jiang JX; Cao X; You JB; Zhou XQ
    Biomed Pharmacother; 2016 Jul; 81():388-393. PubMed ID: 27261617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. H
    Untereiner AA; Oláh G; Módis K; Hellmich MR; Szabo C
    Biochem Pharmacol; 2017 Jul; 136():86-98. PubMed ID: 28404377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting Lactate Dehydrogenase A with Catechin Resensitizes SNU620/5FU Gastric Cancer Cells to 5-Fluorouracil.
    Han JH; Kim M; Kim HJ; Jang SB; Bae SJ; Lee IK; Ryu D; Ha KT
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34065602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.